Caveat: mycoplasma arginine deiminase masquerading as nitric oxide synthase in cell cultures  by Choi, Jae-Woon et al.
Caveat: mycoplasma arginine deiminase masquerading as nitric oxide
synthase in cell cultures
Jae-Woon Choi a, W. Geo¡rey Haigh b, Sum P. Lee b;*
a Department of Surgery, Chungbuk National University Hospital, Chungbuk, South Korea
b Department of Medicine (111GI), VA Medical Center, University of Washington, 1660 S. Columbian Way, Seattle, WA 98108, USA
Received 11 March 1998; revised 19 June 1998; accepted 30 June 1998
Abstract
We used confluent cultures of dog gallbladder epithelial cells, stimulated by conditioned medium from a culture of human
neonatal foreskin fibroblasts, to establish the presence of inducible nitric oxide synthase (NOS, EC 1.14.13.39). Assay was by
conversion of radiolabeled arginine to citrulline. By 4 days after addition of the conditioned medium, a relatively high level of
activity was observed. However, further study showed that the enzyme did not require addition of the usual cofactors for
maximal activity (NADPH, FAD, FMN and tetrahydrobiopterin) and was stable in the absence of anti-proteolytic agents.
Our suspicion that this enzyme might not be NOS but arginine deiminase (EC 3.5.3.6) was confirmed by enzyme purification
and by the liberation of ammonia during enzyme reaction. This enzyme, which is absent from primates and virtually confined
to single-cell organisms, suggested the presence of Mycoplasma, a common contaminant of cell cultures, and it was
subsequently confirmed that the fibroblast culture was a source of Mycoplasma. With the widespread interest in nitric oxide
and NOS, and common use of the convenient [3H]arginine assay, there is a considerable danger of the two enzymes being
confused. At the very least, it is necessary to check for activity in the absence of added cofactors. 0167-4889 / 98 / $ ^ see
front matter ß 1998 Elsevier Science B.V. All rights reserved.
1. Introduction
During the last decade, there has been an increas-
ing level of interest in the biochemical production
and physiology of nitric oxide, which has a role in
vasodilation, macrophage cytotoxicity to tumor cells
and signal transduction in central and peripheral
neurons [1]. The enzyme which produces this com-
pound from arginine, nitric oxide synthase (NOS, EC
1.14.13.39), occurs in three isoforms [2,3], of which
the inducible form, iNOS, helps to kill or suppress
intracellular pathogens, including viruses. The struc-
ture, mechanism of action, cofactors and inhibitors
of this enzyme have been thoroughly reviewed by
Gri⁄th and Stuehr [4].
The reaction producing nitric oxide is complex and
involves two successive mono-oxygenase reactions,
the net result being the conversion of L-arginine to
nitric oxide and L-citrulline. The enzyme contains
one equivalent each of FAD, FMN, tetrahydrobiop-
terin, heme and calmodulin per monomer. Also re-
quired are NADPH and oxygen [4].
Several methods are used for assay of NOS. Direct
measurement of biologically formed NO is di⁄cult
and not well suited to routine use; consequently, a
number of researchers have turned to the convenient
method of Bredt [5] employing conversion of radio-
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labeled arginine to radiolabeled citrulline, with the
latter separated on a short ion-exchange column.
Very often, the addition of NOS agonists or antag-
onists and their e¡ect on citrulline generation is in-
terpreted as involvement (or lack of) with the NOS
pathway [6^11]. Unfortunately, there is another en-
zyme, often forgotten, which also converts arginine
to citrulline, but with the liberation of ammonia
rather than nitric oxide. This is arginine deiminase,
found in a wide variety of microorganisms, including
many species of Mycoplasma [12^14]. While this may
not be a problem in studies with tissues (the enzyme
is not found in primates), that is not the case with
cell cultures. Mycoplasma has been found as a very
common contaminant of cell cultures [15] and is no-
toriously di⁄cult to detect.
Our purpose was to determine the presence of
NOS isoforms in con£uent cultures of dog gallblad-
der epithelial cells. Using the established radiolabeled
arginine test, we consistently found signi¢cant en-
zyme activity; however, the characteristics of the en-
zyme, including its molecular size, appeared di¡erent
from the literature. Subsequently, we found that the
addition of cofactors was unnecessary, as was the use
of anti-proteolytic agents, suggesting that the activity
was that of arginine deiminase, presumably from a
Mycoplasma contamination.
We report an example where the cell culture
showed a high level of arginine deiminase activity,
but initially was stated by an experienced Mycoplas-
ma laboratory to be free of contamination. The en-
zyme has been characterized as to substrates, inhib-
itors, cofactors, stability and molecular size. To
underscore the di⁄culty of de¢ning the contaminant,
repeated e¡orts by a group of experienced Mycoplas-
ma research workers failed to determine the species
of this organism.
2. Materials and methods
2.1. Cell culture
2.1.1. Gallbladder epithelial cells
Normal dog gallbladder epithelial cells (DGBE)
were cultured on Vitrogen by the method previously
described [16]. When cells were sub-con£uent, mixed
media (normal medium plus ¢broblast-conditioned
medium, 1:1 v/v) were added and incubated 4 days.
Cells were harvested and stored at 370‡C until fur-
ther processing.
2.1.2. Other cell lines
Human neonatal foreskin ¢broblasts (BB cells,
passage 7^20) infected with Mycoplasma were cul-
tured in plastic dishes [17] and harvested with trypsi-
nization and centrifugation. Harvested cells were
used at once or frozen using liquid nitrogen and
stored at 370‡C until further processing. The condi-
tioned medium of Mycoplasma-contaminated ¢bro-
blasts was used to infect other cell lines. Gingival
¢broblasts [18], human gallbladder myo¢broblasts
[19], human pulmonary endothelial cells [20], and
dog pancreatic duct epithelial cells (DPDE) [21]
were cultured by established methods previously de-
scribed.
2.2. Measurement of enzyme activity
Extracts were made according to the method of
Shaul et al. [22]. Con£uent cells were washed with
ice-cold PBS (100 mM NaCl, 25 mM NaH2PO4,
80 mM Na2HPO4, pH 7.5) and spun down. The
pellet was resuspended in ice-cold antiprotease solu-
tion (50 mM Tris-HCl, pH 7.4, containing 1.0 mM
EDTA, 5 mM mercaptoethanol, 10 Wg/ml pepstatin
A, 10 Wg/ml leupeptin, 90 Wg/ml phenylmethylsulfon-
yl £uoride) and the cells were homogenized with brief
sonication (15 s). Arginine deiminase activity was
determined by conversion of [3H]arginine to
[3H]citrulline [5]. For this assay, 50 Wl of cell lysate
was mixed with 50 Wl of distilled water which con-
tained 0.4 WCi [3H]arginine (368 mCi/mmol; ¢nal
concentration 1 WM). After incubation at 37‡C for
30 min, the reaction was terminated by addition of
400 Wl of 40 mM HEPES bu¡er pH 5.5. The samples
were applied to 1 ml columns of Dowex AG 50WX-8
(Na form) and eluted with 3U1 ml of distilled water.
Eluted fractions were collected and counted on a
Packard 1600 TR liquid scintillation analyzer (Pack-
ard Instruments, Downers Grove, IL).
Where cofactors required for NOS activity were
added to the incubation mixtures, the ¢nal concen-
trations were as in [22]: 2 mM NADPH, 2 WM tet-
rahydrobiopterin, 10 WM FAD, 10 WM FMN,
0.5 mM CaCl2 in excess of EDTA, 15 nM calmodu-
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lin, 2 WM unlabeled L-arginine, 2 WCi/ml of
L-[3H]arginine.
2.3. Con¢rmation of enzyme identity
The identity of arginine deiminase was con¢rmed
in three ways: (a) conversion of radiolabeled arginine
to citrulline as described above, (b) demonstration of
activity in the above test in the absence of any of the
cofactors required for nitric oxide synthase activity,
as described in Section 3, and (c) demonstration of
production of ammonia during the reaction by qual-
itative use of the Nessler reagent, prepared according
to the ¢rst method described in [23]. The reaction
was allowed to proceed in the presence of unlabeled
arginine with (a) the active enzyme preparation, or
(b) boiled enzyme preparation.
2.4. Puri¢cation of arginine deiminase
Thirty 2-liter roller bottle cultures of the ¢bro-
blasts were trypsinized and the cells precipitated by
centrifugation. The pellets were sonicated for 20 s in
antiprotease solution [22], using a Branson 200 Cell
Disruptor (Branson, Danbury, CN) with micro-
probe. The suspension was centrifuged at 100 000Ug
for 90 min in a Beckman L2 65B ultracentrifuge
(Beckman Instruments, Spinco Divn., Palo Alto,
CA) and the supernatant fraction precipitated by
60% saturation with ammonium sulfate at 0‡C with
stirring for 1 h. After centrifugation, the supernatant
was dialyzed against ¢ve changes of 10 mM potassi-
um phosphate, pH 7.4, to remove the ammonium
sulfate. The sample was concentrated in the dialysis
tubing with the external application of Aquacide
(Calbiochem, La Jolla, CA), centrifuged and the
supernatant applied to a 1.5U30 cm ion-exchange
column of DEAE-Sephacel (Pharmacia, Piscataway,
NJ) which had been equilibrated with 10 mM potas-
sium phosphate bu¡er/10% glycerol/0.5 mM argi-
nine, pH 7.5, containing 10 mM NaCl [24]. After
washing the column with the same bu¡er until no
further protein eluted, the deiminase was eluted
with the same phosphate bu¡er containing 80 mM
NaCl. The eluate was dialyzed against distilled water
to remove the salts and then lyophilized.
The above material was applied to a non-denatur-
ing PAGE gel 20U20 cm, 1.5 mm thick and electro-
phoresed until the bromophenol blue marker was 0.5
in. from the bottom. The active portion (pre-deter-
mined by elution from an analytical gel and testing
of fractions for conversion of [3H]arginine to citrul-
line) was cut out and the enzyme eluted from the gel
and lyophilized. An aliquot was assayed to con¢rm
activity and another aliquot was run on SDS-PAGE
to con¢rm the molecular size.
3. Results
3.1. Characteristics of Mycoplasma sp. infection
Although the conditioned medium contained a
very low level of deiminase activity, and thus only
a very low level of free Mycoplasma, it was able to
infect other cell lines (Fig. 1), even after ¢ltration
through a 0.45 Wm ¢lter (Mycoplasma has a diameter
of 0.3^0.8 Wm). Infection of a variety of cell cultures
(DGBE, DPDE, human gingival ¢broblasts, human
gallbladder myo¢broblasts, human pulmonary endo-
thelial cells, human common bile duct epithelial cells)
with contaminated medium did not change the pH of
the infected cell medium, nor did it produce turbidity
in the medium. Cell growth and cell morphology
were not a¡ected, although the Mycoplasma lives
mainly within the cells. Deiminase activity was slow
to develop in the infected cell cultures (Fig. 2) and
Fig. 1. Arginine deiminase activity of cell lines with and with-
out Mycoplasma infection. A, blank, i.e. L-[3H]arginine without
cell lysate; B, label+lysate from uninfected DGBE cells ; C, la-
bel+lysate from infected DGBE cells ; D, label+lysate from un-
infected HPDE cells ; E, label+lysate from infected HPDE cells.
BBAMCR 14354 8-9-98
J.-W. Choi et al. / Biochimica et Biophysica Acta 1404 (1998) 314^320316
the curve of activity markedly resembles a typical
logarithmic growth curve shown by most unicellular
microorganisms, thus the deiminase activity re£ects
the growth of Mycoplasma cells in the newly infected
culture.
3.2. Partial puri¢cation of arginine deiminase
Unlike NOS [3], arginine deiminase did not bind
to an ADP-Sepharose column, but was eluted with
the wash bu¡er (data not shown). On ion-exchange
chromatography (DEAE-Sephacel), the peak of ac-
tivity was eluted with 80 mM NaCl, whereas NOS
requires 120 mM NaCl [24,25].
On preparative isoelectric focusing, the enzyme ac-
Fig. 5. Lack of feedback inhibition of arginine deiminase activ-
ity by citrulline. A, labeled arginine without cell lysate; B, la-
bel+lysate from Mycoplasma-infected DGBE cells ; C, as in B,
but with 5 mM L-citrulline; D, as in B, but with 50 mM L-cit-
rulline.
Fig. 4. Arginine deiminase activities of Mycoplasma-infected
DGBE cells and ¢broblasts, with and without cofactors
(NADPH, FAD, FMN, tetrahydrobiopterin, calmodulin, calci-
um). A, labeled arginine+lysate from uninfected DGBE cells ;
B, label+lysate from infected DGBE cells+cofactors; C, as in
B, but no cofactors; D, label+lysate from infected ¢broblasts+-
cofactors; E, as in D, but no cofactors.
Fig. 3. SDS-PAGE of arginine deiminase from Mycoplasma.
(A) 10% polyacrylamide gel. (B) 4^20% polyacrylamide gradient
gel. The right hand lanes in each case contain molecular mass
standards.
Fig. 2. Arginine deiminase activity in Mycoplasma-infected
DGBE cells versus time from infection.
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tivity did not form a single sharp peak, in agreement
with a previous report by Weickmann and Fahrney
[26]. In the native PAGE, after DEAE separation,
there were seven silver-staining bands, of which
only the ¢rst band (lowest mobility) was active.
When this fraction was applied to 10% or gradient
SDS-PAGE, a single major band of molecular mass
approx. 45 kDa was seen (Fig. 3).
3.3. Characteristics of arginine deiminase from
Mycoplasma sp.
Unlike NOS, the deiminase does not require any
added cofactors (Fig. 4), nor does it need anti-pro-
tease protection. It is stable to multiple freeze/thaw-
ing and stable in the refrigerator for at least 1 month.
Unlike NOS, arginine deiminase liberates ammonia.
This was demonstrated qualitatively after enzyme in-
cubation by the addition of Nessler’s reagent, with
the production of a strong yellow-brown color in the
active enzyme preparation, but no color development
in the boiled control. Thin-layer chromatography of
the reaction products, with scraped fractions counted
in a scintillation counter, showed the presence of
labeled citrulline, but not ornithine.
In agreement with Smith et al. [27], we observed
no feedback inhibition of activity by citrulline (Fig.
5), and this enzyme utilized not only L-arginine but
also D-arginine as substrate. L-Arginine analogues
(L-NAME, N-monomethyl-L-arginine) inhibit the ac-
tivity (Fig. 6), as is the case with NOS.
When the cells were sonicated for a longer time
period (60 s) to release the enzyme, subsequent elu-
tion from the DEAE column showed deiminase ac-
tivity in two peaks, one in the starting bu¡er in ad-
dition to the usual one in 80 mM NaCl.
4. Discussion
Nitric oxide is generated by conversion of L-argi-
nine and molecular oxygen to L-citrulline by the en-
zyme nitric oxide synthase (NOS). The activity of
NOS can be determined conveniently by measuring
conversion of radiolabeled arginine to citrulline [5].
However, 30^80% of cell lines have been reported to
be infected by Mycoplasma [15]. Arginine deiminase
is widely distributed in unicellular organisms, includ-
ing Mycoplasma. This enzyme catalyzes the hydroly-
sis of a C-N bond in the guanidino group of arginine
and related guanidine derivatives with liberation of
ammonia and production of citrulline.
The non-fermenting species and a few fermenting
species of Mycoplasma hydrolyze arginine by a three-
enzyme ‘dihydrolase pathway’ involving arginine de-
iminase, ornithine carbamyl transferase, and carba-
mate kinase [12]. Arginine is converted to citrulline
and then to ornithine plus carbamyl phosphate,
which is hydrolyzed to ammonia and carbon dioxide,
with production of ATP [28]. This pathway accounts
for the major portion of ATP generation in these
Mycoplasma species.
The arginine dihydrolase pathway is primarily
found in prokaryotic organisms and has been ob-
served in Pseudomonas [29,30], Bacillus [31], acetic
acid bacteria [32], Clostridia [33], and Mycoplasma
[34,35]. In our system, however, there was no pro-
duction of labeled ornithine, perhaps due to insu⁄-
cient cofactors in the crude system, and loss of the
other enzymes as well as cofactors in more puri¢ed
preparations.
4.1. Comparison with previously published arginine
deiminases
The molecular mass of arginine deiminase from
Fig. 6. The e¡ect of L-arginine and its analogues on the activity
of arginine deiminase in lysates of Mycoplasma-infected DGBE
cells. A, label with lysate from Mycoplasma-infected DGBE
cells ; B, as in A+5 mM L-NAME; C, as in A+50 mM
L-NAME; D, as A+5 mM N-monomethyl-L-arginine; E, as in
A+50 mM N-monomethyl-L-arginine; F, as in A+5 mM un-
labeled L-arginine; G, as in A+50 mM unlabeled L-arginine; H,
as in A+5 mM D-arginine; I, as in A+50 mM D-arginine.
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Mycoplasma arthritidis on SDS-PAGE is approx. 49
kDa [26]; that of arginine deiminase from Mycoplas-
ma arginini on SDS-PAGE is 45 kDa [36,37]. The
molecular mass of our puri¢ed protein on SDS-
PAGE also is approx. 45 kDa (Fig. 3). N-Mono-
methyl-L-arginine, D-arginine, homoarginine, and ar-
gininic acid undergo enzymic hydrolysis by the de-
iminase 200^3000 times more slowly than L-arginine
[27]. In our study, D-arginine, L-NAME, and N-
monomethyl-L-arginine inhibit production of radio-
labeled citrulline from L-arginine (Fig. 6).
4.2. Use as a screening test
Detection of arginine deiminase has been used as a
screening test for Mycoplasma contamination in cell
culture [38]. Measuring radiolabeled citrulline is very
sensitive and speci¢c ^ nanomolar concentrations of
radiolabeled citrulline produced from radiolabeled
arginine are detected in this method. Furthermore,
arginine deiminase is very stable and does not need
any cofactors. This biochemical method has, how-
ever, serious limitations as a screening for Mycoplas-
ma infection, in that many species of Mycoplasma
lack arginine deiminase. As a testimony to the di⁄-
culty of detecting and identifying this common con-
taminant in cell cultures, ¢rst results were negative
and we have not been able to determine the species
of the contaminant in our cell cultures (G.E. Kenny,
personal communication). However, a recently an-
nounced PCR test from ATCC (American Type Cul-
ture Collection, Manassas, VA) promises to simplify
the detection and identi¢cation of this problematic
contaminant.
4.3. Enzyme isoforms
In preparing the arginine deiminase, if the precip-
itate was sonicated for an additional 1 min, it was
found that further activity was released. The super-
natants from the two sonications were combined and
worked up as one. When this mixture was applied to
preparative IEF over a limited pH range (pH 5^9),
two peaks of activity were obtained (data not
shown), as was seen also on the DEAE column.
These ¢ndings are in agreement with those of Weick-
mann and Fahrney [26], who reported the occurrence
of two forms on isoelectric focusing in M. arthritidis.
However, in the latter case, this was due to presence
of a monomer and a dimer. This does not seem likely
to explain a di¡erence in enzyme liberation according
to sonication time, which may instead suggest a dif-
ferent cellular location of isoforms.
While three forms of NOS (endothelial, neuronal
and inducible) have been widely studied over the past
decade [1], use of the [3H]arginine assay has only
infrequently been accompanied by studies of activity
in the absence of cofactors, or of the enzyme char-
acteristics. Thus, there remains the possibility that
NOS activity could have been confused with arginine
deiminase. Because Mycoplasma is such a common
and problematic contaminant, even in laboratories
with strict quality control, we fear that a number
of investigators may not be aware of the existence
of exogenous arginine deiminase. We advocate vali-
dating measures to ascertain the authenticity of
NOS activity whenever cell or tissue cultures are
used.
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